In accordance with section 29 of the Danish Securities Trading Act, Novozymes
hereby announces that it has been informed that Baillie Gifford & Co (through
holdings in Baillie Gifford & Co, and through its wholly owned subsidiary,
Baillie Gifford Overseas Limited) has increased its holding of B shares in
Novozymes A/S to a total of 25,388,300 B shares of a nominal value of DKK
50,776,600, equivalent to 7.81% of Novozymes A/S' share capital and 3.14% of
the voting rights.
Read the full announcement.
Attachment:
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=391573
Attachment:
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=391573
© 2012 GlobeNewswire
